blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3766343

EP3766343 - NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN LOCUS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.03.2023
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  08.04.2022
FormerGrant of patent is intended
Status updated on  21.11.2021
FormerRequest for examination was made
Status updated on  23.07.2021
FormerThe application has been published
Status updated on  18.12.2020
Most recent event   Tooltip17.03.2023No opposition filed within time limitpublished on 19.04.2023  [2023/16]
Applicant(s)For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
[2021/03]
Inventor(s)01 / GUO, Chunguang
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
02 / HARRIS, Faith
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
03 / VORONINA, Vera
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
04 / MCWHIRTER, John
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
05 / LEVENKOVA, Natasha
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
06 / MACDONALD, Lynn
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
07 / TU, Naxin
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
08 / MURPHY, Andrew J
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
 [2021/03]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2022/19]
Former [2021/03]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date20180508.203.11.2017
[2021/03]
Priority number, dateUS201662417845P04.11.2016         Original published format: US 201662417845 P
US201762567932P04.10.2017         Original published format: US 201762567932 P
[2021/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3766343
Date:20.01.2021
Language:EN
[2021/03]
Type: B1 Patent specification 
No.:EP3766343
Date:11.05.2022
Language:EN
[2022/19]
Search report(s)(Supplementary) European search report - dispatched on:EP23.12.2020
ClassificationIPC:A01K67/027, C12N15/90, C12N15/85, C07K16/00
[2021/03]
CPC:
A01K67/0278 (EP,CN,IL,KR,RU,US); C07K16/00 (EP,CN,IL,RU,US); C07K16/18 (KR);
C12N15/8509 (CN,KR); C12N15/907 (EP,CN,IL,KR,RU,US); A01K2207/15 (EP,IL,KR,US);
A01K2217/05 (CN,KR,US); A01K2217/072 (EP,CN,IL,KR,US); A01K2217/075 (EP,IL,KR,US);
A01K2227/105 (EP,CN,IL,KR,US); A01K2267/01 (EP,CN,IL,KR,US); C07K2317/14 (EP,CN,IL,KR,US);
C07K2317/24 (EP,CN,IL,KR,US); C12N2015/8518 (EP,IL,KR,US); C12N2800/107 (CN);
C12N2800/30 (EP,CN,IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/34]
Former [2021/03]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA15.07.2021
ME15.07.2021
Validation statesMA15.07.2021
MD15.07.2021
TitleGerman:NICHTHUMANE TIERE MIT MANIPULIERTEM IMMUNGLOBULIN-LAMBDA-LEICHTKETTEN-LOCUS[2021/03]
English:NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN LOCUS[2021/03]
French:ANIMAUX NON HUMAINS AYANT UN LOCUS À CHAÎNE LÉGÈRE LAMBDA D'IMMUNOGLOBULINE MODIFIÉE[2021/03]
Examination procedure15.07.2021Amendment by applicant (claims and/or description)
15.07.2021Examination requested  [2021/34]
15.07.2021Date on which the examining division has become responsible
22.11.2021Communication of intention to grant the patent
30.03.2022Fee for grant paid
30.03.2022Fee for publishing/printing paid
30.03.2022Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP17863293.1  / EP3407709
Divisional application(s)EP22164751.4  / EP4082334
Opposition(s)14.02.2023No opposition filed within time limit [2023/16]
Fees paidRenewal fee
17.06.2020Renewal fee patent year 03
19.11.2020Renewal fee patent year 04
18.11.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2013096142  (REGENERON PHARMA [US]) [A] 1-14* page 73 - page 106; figure 23B *;
 [X]US2014283150  (BRADLEY ALLAN [GB], et al) [X] 1-14 * paragraph [0081] - paragraph [0100] * * paragraph [0385] - paragraph [0387] * * paragraph [1200] - paragraph [1237] * * claims 7-13 *
by applicantUS5670356
 US5874304
 WO0236789
 US2002088016
 US6586251
 US6596541
 US2003217373
 US6998514
 US7105348
 US7435871
 US7582298
 US2011236378
 US2013096287
 US8502018
 US8642835
 US8697940
 US8791323
 US2014235933
 US9006511
 US9012717
 US9029628
 US9035128
 US2015159174
 US9066502
 US9150662
 US9163092
 US2015376650
 US2015376628
 US9228208
 US2016060657
 US2016145646
 US2016177339
    - GONNET, G.H. et al., Science, (19920000), vol. 256, pages 1443 - 1445
    - BRUGGEMANN, M. et al., Proc. Nat. Acad. Sci. U.S.A., (19890000), vol. 86, pages 67 - 09,13
    - GREEN, L.L. et al., Nat. Genet., (19940000), vol. 7, pages 13 - 21
    - HOOGENBOOM, H. R., TIB Tech., (19970000), vol. 15, pages 62 - 70
    - AZZAZY, H.W.E. HIGHSMITH, Clin. Biochem., (20020000), vol. 35, pages 425 - 45
    - GAVILONDO, J. V.J.W. LARRICK, BioTechniques, (20020000), vol. 29, pages 128 - 45
    - HOOGENBOOM H.P. CHAMES, Immunol. Today, (20000000), vol. 21, pages 364 - 70
    - TAYLOR, L. D. et al., Nucl. Acids Res., (19920000), vol. 20, pages 6287 - 6295
    - KELLERMANN, S-A.L.L. GREEN, Curr. Opin. Biotechnol., (20020000), vol. 13, pages 593 - 7
    - OSBORN, M.J. et al., J. Immunol., (20130000), vol. 190, pages 1481 - 90
    - LEE, E-C. et al., Nat. Biotech., (20140000), vol. 32, no. 4, pages 356 - 63
    - MACDONALD, L.E. et al., Proc. Natl. Acad. Sci. U.S.A., (20140000), vol. 111, no. 14, pages 5153 - 5158
    - ALTSCHUL, S. F. et al., J. Mol. Biol., (19900000), vol. 215, no. 3, pages 403 - 10
    - ALTSCHUL, S.F. et al., Meth. Enzymol., (19960000), vol. 266, pages 460 - 80
    - ALTSCHUL, S.F. et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 402
    - GREEN, L.L. et al., J. Exp. Med., (19980000), vol. 188, pages 483 - 95
    - BRUGGEMANN, M. et al., Arch. Immunol. Ther. Exp., (20150000), vol. 63, pages 101 - 8
    - BRUGGEMANN, M. et al., Eur. J. Immunol., (19910000), vol. 21, pages 1323 - 6
    - DAVIES, N.P. et al., Biotechnol., (19930000), vol. 11, pages 911 - 4
    - LONBERG, N. et al., Nature, (19940000), vol. 368, pages 856 - 9
    - TAYLOR, L.D. et al., Int. Immunol., (19940000), vol. 6, pages 579 - 91
    - WAGNER, S.D. et al., Eur. J. Immunol., (19940000), vol. 24, pages 2672 - 81
    - FISHWILD, D.M. et al., Nat. Biotechnol., (19960000), vol. 14, pages 845 - 51
    - WAGNER, S.D. et al., Genomics, (19960000), vol. 34, pages 213 - 218
    - MENDEZ, M.J. et al., Nat. Genet., (19970000), vol. 15, pages 146 - 56
    - XIAN, J. et al., Transgenics, (19980000), vol. 2, pages 333 - 43
    - KELLERMANN, S.A.L.L. GREEN, Cur. Opin. Biotechnol., (20020000), vol. 13, pages 593 - 7
    - NICHOLSON, I.C. et al., J. Immunol., (19990000), vol. 163, pages 6898 - 906
    - POPOV, A.V. et al., J. Exp. Med., (19990000), vol. 189, no. 10, pages 1611 - 19
    - SHIZUYA et al., Proc. Natl. Acad. Sci., (19920000), vol. 89, pages 8794 - 8797
    - SWIATEK et al., Genes and Development, (19930000), vol. 7, pages 2071 - 2084
    - OSOEGAWA, K. et al., Genome Res., (20010000), vol. 11, no. 3, pages 483 - 96
    - OSOEGAWA, K. et al., Genomics, (19980000), vol. 52, pages 1 - 8
    - DUNHAM, I. et al., Nature, (19990000), vol. 402, pages 489 - 95
    - POPOV, A.V. et al., Gene, (19960000), vol. 177, pages 195 - 201
    - Molecular Biology of B Cells, Elsevier Academic Press, (20040000), pages 37 - 59
    - AUERBACH, W. et al., Biotechniques, (20000000), vol. 29, no. 5, pages 1024 - 1028,1030,1032
    - MENDEZ, M.J. et al., Nat. Genetics, (19970000), vol. 15, no. 2, pages 146 - 56
    - JAKOBOVITS, A. et al., Ann. NY Acad. Sci., (19950000), vol. 764, pages 525 - 35
    - RAJEWSKI, K. et al., J. Clin. Invest., (19960000), vol. 98, no. 3, pages 600 - 3
    - ORBAN, P.C. et al., Proc. Natl. Acad. Sci. U.S.A., (19920000), vol. 89, pages 6861 - 5
    - O'GORMAN, S. et al., Science, (19910000), vol. 251, pages 1351 - 5
    - FESTING et al., Mammalian Genome, (19990000), vol. 10, page 836
    - VALENZUELA et al., Nature Biotech., (20030000), vol. 21, no. 6, pages 652 - 9
    - ASENBAUER, H.H.G. KLOBECK, Eur. J. Immunol., (19960000), vol. 26, no. 1, pages 142 - 50
    - LAKSO, M. et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 6232 - 6
    - GU, H. et al., Cell, (19930000), vol. 73, no. 6, pages 1155 - 64
    - ARAKI, K. et al., Proc. Natl. Acad. Sci. U.S.A., (19950000), vol. 92, pages 160 - 4
    - DYMECKI, S.M., Proc. Natl. Acad. Sci. U.S.A., (19960000), vol. 93, no. 12, pages 6191 - 6
    - DECHIARA, T.M. et al., Methods Enzymol., (20100000), vol. 476, pages 285 - 294
    - DECHIARA, T.M., Methods Mol. Biol., (20090000), vol. 530, pages 311 - 324
    - POUEYMIROU et al., Nat. Biotechnol., (20070000), vol. 25, pages 91 - 99
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.